Literature DB >> 3491707

Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis.

A Shore, S Jaglal, E C Keystone.   

Abstract

Twenty-one patients with rheumatoid arthritis (RA) and 12 age and sex matched healthy controls were examined for the ability of their monocytes (adherent cells, AC) to spontaneously secrete interleukin 1 (IL-1) and for their peripheral blood mononuclear cells (PBMC) to secrete interleukin 2 (IL-2) induced by Staphylococcal Protein A (SPA). All RA patients had PBMC which secreted normal amounts of mitogen induced IL-2 regardless of disease activity or disease history. However, AC from RA patients who had a recent (less than 6 months) onset of their disease, or exacerbation of existing RA, had enhanced spontaneous IL-1 secretion. AC from patients with equally active RA but with historically stable disease generated normal amounts of IL-1. Enhanced in vitro IL-1 generation by circulating monocytes is temporally linked to an early event in the onset of exacerbation of RA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491707      PMCID: PMC1542310     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Further studies on the antipyretic action of polymyxin B in pyrogen-induced fever.

Authors:  A S van Miert; C T van Duin
Journal:  Arzneimittelforschung       Date:  1978

2.  Monocyte metabolic activation in patients with rheumatoid arthritis.

Authors:  N E Kay; S D Douglas
Journal:  Proc Soc Exp Biol Med       Date:  1979-07

3.  Basis for the probit analysis of an interferon plaque reduction assay.

Authors:  G W Jordan
Journal:  J Gen Virol       Date:  1972-01       Impact factor: 3.891

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Staphylococcal protein A, a T cell-regulated polyclonal activator of human B cells.

Authors:  P E Lipsky
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Proliferation of murine thymic lymphocytes in vitro is mediated by the concanavalin A-induced release of a lymphokine (costimulator).

Authors:  V Paetkau; G Mills; S Gerhart; V Monticone
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

7.  Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

Authors:  S Limatibul; A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

8.  Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.

Authors:  B Combe; R M Pope; M Fischbach; B Darnell; S Baron; N Talal
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

9.  T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity.

Authors:  H Wagner; M Röllinghoff
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  The functional relationship of the interleukins.

Authors:  K A Smith; L B Lachman; J J Oppenheim; M F Favata
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  26 in total

1.  Detection of circulating Fc epsilon R2/CD23+ monocytes in patients with rheumatic diseases.

Authors:  H Becker; P Potyka; C Weber; K Federlin
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 2.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

Review 3.  Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.

Authors:  Z Szekanecz; A E Koch; S L Kunkel; R M Strieter
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

4.  Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation.

Authors:  I G Otterness; H W Golden; W H Brissette; P A Seymour; G O Daumy
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis.

Authors:  J W Fuseler; E M Conner; J M Davis; R E Wolf; M B Grisham
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

6.  Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors.

Authors:  Audrey Paoletti; Julien Rohmer; Bineta Ly; Juliette Pascaud; Elodie Rivière; Raphaele Seror; Benoit Le Goff; Gaetane Nocturne; Xavier Mariette
Journal:  J Immunol       Date:  2019-09-04       Impact factor: 5.422

7.  Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.

Authors:  A S Williams; S G Jones; R M Goodfellow; N Amos; B D Williams
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

8.  Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls.

Authors:  S Ruschen; W Stellberg; H Warnatz
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

9.  Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD).

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Sumiya; R Yokohari
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

10.  Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro.

Authors:  A Mackiewicz; M Sobieska; M Kapciñska; S H Mackiewicz; K E Wiktorowicz; T Pawłowski
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.